Renaissance Technologies - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q3 2023$1,890
+1177.0%
598,000
+166.5%
0.00%
Q2 2023$148
-25.6%
224,400
-10.1%
0.00%
Q1 2023$199
-83.1%
249,600
-52.0%
0.00%
-100.0%
Q4 2022$1,175
-99.9%
519,800
+24.2%
0.00%
+100.0%
Q3 2022$808,000
-58.5%
418,500
-20.1%
0.00%
-50.0%
Q2 2022$1,948,000
+19.3%
523,600
+109.0%
0.00%0.0%
Q1 2022$1,633,000250,5000.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,827,926$12,096,2468.11%
TCG Crossover Management, LLC 11,111,111$35,111,1115.17%
VR Adviser, LLC 14,444,444$45,644,4434.80%
Kynam Capital Management, LP 3,281,313$10,368,9491.70%
Ghost Tree Capital, LLC 1,325,000$4,187,0001.38%
Octagon Capital Advisors LP 2,777,778$8,777,7781.35%
RA Capital Management 18,472,503$58,373,1091.15%
RTW INVESTMENTS, LP 16,893,185$53,382,4651.13%
Diametric Capital, LP 760,014$2,401,6441.00%
Quantum Private Wealth, LLC 575,380$1,818,2010.87%
View complete list of TAYSHA GENE THERAPIES INC shareholders